IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 6657 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Pharmacological treatment of diabetes in older people
W. M. Valencia,H. Florez
Diabetes, Obesity and Metabolism.2014;16(12)1192
2Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Mohd Faizan,Alika Sarkar,Mahendra Pratap Singh
Ageing Research Reviews.2022;81(12)101727
3Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Alexander Olegovich Shpakov
Ageing Research Reviews.2018;81(12)101727
4Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
Alfredo Briones-Aranda,Javier Ramírez-Carballo,Bernardo Alfredo Romero Gómez,Victor Manuel Vega Villa,Manuela Castellanos Pérez,Esmeralda Garcia Parra,Hugo Roberto Santeliz-Montero
Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2018;25(1)59
5The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials
Ida Brandt Andersen,Mikkel Andreassen,Jesper Krogh
Diabetes, Obesity and Metabolism.2021;23(1)58
6Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Maka Siamashvili,Stephen Davis
Expert Opinion on Pharmacotherapy.2021;22(2)241
7Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Fauze Camargo Maluf,David Feder,Alzira Alves de Siqueira Carvalho
Parkinson's Disease.2019;2019(2)1
8Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus
Stanley S. Schwartz,Farhad Zangeneh
Postgraduate Medicine.2016;128(8)828
9Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus
Md. Tanvir Kabir,Jannatul Ferdous Mitu,Raushanara Akter,Muhammad Furqan Akhtar,Ammara Saleem,Ahmed Al-Harrasi,Saurabh Bhatia,Md. Sohanur Rahman,Fouad Damiri,Mohammed Berrada,Md. Habibur Rahman
Environmental Science and Pollution Research.2022;29(31)46385
10Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA.2015;1(3)46385
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow